Blastomycosis Treatment Market Trends

  • Report ID: 3667
  • Published Date: Mar 31, 2023
  • Report Format: PDF, PPT

Blastomycosis Treatment Market Trends

Growth Drivers

  • Growing Population of Immunocompromised Patients – On account of the increasing immunodeficiencies, and malnutrition the market is expected to expand more in the upcoming years. Further, patients with weakened immune systems are more vulnerable to bacterial, fungal, viral, and parasitic illnesses. According to estimates, there are over 9 million immunocompromised individuals in the US, which is more than 3% of the total population.

  • Rising Geriatric Population – The elderly population is more prone to fungal infections owing to a weakened immune system is estimated to drive market growth. As of 2050, the number of individuals over 60 in the world is expected increase by over 2 billion.

  • Increasing Health Care Spending – According to the most recent expenditure data, U.S. health care spending increased by over 2% in 2021. It is predicted that this boom would continue over the forecast period.

  • Growing Prevalence of Malnutrition – It is expected that rising poverty is anticipated to drive the incidence of malnutrition which is further expected to propel the market growth. The World Health Organization (WHO) estimates that undernutrition accounts for over 45% of child mortality in low- and middle-income countries.


  • Diagnoses of Blastomycosis can be Challenging - The increasing concern amongst individuals for the difficulty associated with the diagnosis is one of the major factors predicted to slow down the market growth. For instance, the position of radiographic findings in pulmonary blastomycosis might vary, which can result in an inaccurate diagnosis.

  • Growing Availability of Generic Medicines in the Market

  • Exorbitant Cost of Treatment

Blastomycosis Treatment Market: Key Insights

Base Year


Forecast Year




Base Year Market Size (2022)

~ USD 178 Million

Forecast Year Market Size (2035)

~ USD 286 Million

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:

Author Credits:  Radhika Pawar

  • Report ID: 3667
  • Published Date: Mar 31, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Growing population of immunocompromised patients and the rising geriatric population are the major factors driving the market growth.

The market is anticipated to attain a CAGR of 6% over the forecast period, i.e., 2023-2035.

Diagnoses of blastomycosis can be challenging, and exorbitant cost of treatment are estimated to be the growth hindering factors for the market expansion.

The market in the Asia Pacific region is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.

The major players in the market are Novartis AG, Sanofi-aventis Groupe, Abbott Laboratories, Viatris Inc., Merck & Co., Inc., Siemens Healthcare GmbH, Pfizer Inc., and others.

The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.

The market is segmented by treatment, anatomy, end user, and by region.

The medication segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.
Inquiry Before Buying Request Free Sample

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying